Home › Prostate Cancer › NCT07910019

Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers

Who can join

Ages 18 and older · Men

Inclusion Criteria:

* AIM 1:

  * Diagnosis (or presumed diagnosis) of primary Prostate cancer
  * 18 years of age or older
  * Has a planned visit to a University of Minnesota Cancer Clinic
  * Willing and able to sign voluntary written consent

Exclusion Criteria:

* AIM 1:

  * Inability or unwillingness to give written informed consent

About the study

This study collects, stores and analyzes blood specimens and information from people with prostate cancer. This may help researchers understand whether certain white blood cells involved in immunity differs between prostate cancer patients from various racial backgrounds.

What is being tested

• Non-Interventional Study (other)

Sponsor: Masonic Cancer Center, University of Minnesota · Participants: 45 · Started: Oct 8, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07910019

Locations in the U.S.

Conditions

• Prostate Cancer

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.